Epithelioid Sarcoma Market is driven by Innovative Therapies

bir ses eklendi Health

2025-05-30 13:17:39 -

Epithelioid sarcoma represents a rare soft tissue cancer requiring specialized diagnostic assays, targeted drug therapies, and advanced imaging solutions. Key products include molecular diagnostic kits for INI1 loss detection, histopathology reagents, PET/CT imaging systems, and novel small-molecule inhibitors such as EZH2 antagonists. These solutions offer advantages like precise tumor...

0 Yorumlar 0 hisse senetleri 147 Views 0 önizleme